RecruitingPhase 3NCT05914155
Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome
Studying Non-genetic systemic disease with glomerulopathy as a major feature
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shoichi Maruyama MD PhD
- Principal Investigator
- Shoichi Shoichi, PhD, MDNagoya University Hospital
- Intervention
- Rituximab (genetical recombination)(drug)
- Enrollment
- 88 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2023 – 2027
Study locations (18)
- Anjo Kosei Hospital, Anjo, Aichi-ken, Japan
- Kasugai Municipal Hospital, Kasugai, Aichi-ken, Japan
- Konan Kosei Hospital, Kōnan, Aichi-ken, Japan
- Nagoya University Hospital, Nagoya, Aichi-ken, Japan
- Fujita Health University hospital, Toyoake, Aichi-ken, Japan
- Juntendo University Urayasu Hospital, Urayasu, Chiba, Japan
- Kyushu University Hospital, Fukuoka, Fukuoka, Japan
- Kurume University Hospial, Kurume, Fukuoka, Japan
- Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan
- Kanazawa University Hospital, Kanazawa, Ishikawa-ken, Japan
- Kumamoto University Hospital, Kumamoto, Kumamoto, Japan
- University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
- Kyoto University Hospital, Kyoto, Kyoto, Japan
- Mie University Hospial, Tsu, Mie-ken, Japan
- Tohoku University Hospital, Sendai, Miyagi, Japan
- +3 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05914155 on ClinicalTrials.govOther trials for Non-genetic systemic disease with glomerulopathy as a major feature
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07271186Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseaseRegeneron Pharmaceuticals
- RECRUITINGNANCT06622915Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic SyndromeSohag University
See all trials for Non-genetic systemic disease with glomerulopathy as a major feature →